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Synthesis and Conformational Analysis of Peptides Embodying 
2,3-Methanopipecolic Acids  
Luciano Ricci,
a
 Lorenzo Sernissi,
a,b
 Dina Scarpi,
a
 Francesca Bianchini,
c
 Alessandro Contini,
d
 and 
Ernesto G. Occhiato
a
* 
The conformational analysis of linear and cyclic peptides incorporating 2,3-methanopipecolic acids (or Cyclopropane 
Pipecolic Acids, CPAs) as conformationally constrained α-amino acids is reported. Compared to peptides containing proline 
or pipecolic acid, a striking increase of the cis isomer (42-92%) around the CPA amide bond is observed, both in water and 
organic solvent, when these unnatural amino acids are embodied in linear amino acid sequences. The rotational barrier 
around the same bond in water was calculated, resulting comparable to that for the prolyl cis/trans isomerization.  In 
organic solvent, CPAs at the i+2 position of a peptide induce the formation of a type VIa β-turn secondary structure. When 
incorporated into a cyclic peptide, the cis geometry around the 2,3-methanopipecolic amide bond is still prevailing and, in 
the example studied herein (a cyclic RGD-containing ligand of αVβ3 integrin mimicking Cilengitide), conservation of the 
backbone geometry and side chain spatial orientation of the native peptide is also found. Given the importance of the 
proline cis/trans isomerism in many biological processes, CPAs could be useful as proline mimetics for probing protein-
ligand interactions and generating novel bioactive compounds. 
Introduction 
Peptidomimetics are compounds designed to mimic the 
secondary structure of natural peptides or protein segments in 
order to attain enhanced activity and selectivity toward the 
biologic target.1 The major issue in the rational design of 
peptidomimetics is the intrinsic flexibility of peptides which in 
most cases exist in numerous dynamically interconverting 
conformations. A strategy to lock the amino acid sequence 
into the active conformation is to incorporate some 
constraints and, to this end, a classic approach is to embody 
conformationally restricted building blocks like unnatural 
amino acids.1 Among these, cyclopropane amino acids have 
been widely employed to reduce the conformational mobility 
in peptidomimetics2-4 because of the rigidity and the partial 
unsaturated character of the three-membered ring.5 For 
instance, rigid α-amino acids have been obtained by merging 
proline to a cyclopropane ring to form many 2,3-,6 3,4-7 and 
4,5-methanoprolines8,9 which allowed for the synthesis of 
bioactive compounds and peptides with defined secondary 
structure.10  
This approach has been investigated less systematically with 
pipecolic acid, the six-membered ring homologue of proline, as 
only scattered examples of methanopipecolic acids (Figure 1a) 
are present in the literature.8a,10h,11 On the other hand, 
pipecolic acids are components of a wide range of 
pharmacologically active compounds, including 
cyclopeptides,12  and a more extensive exploration of the 
chemical space around methanopipecolic  
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Figure 1. Selected examples of cyclopropane-fused pipecolic acid derivatives 
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acids could lead to the design of bioactive peptides with 
specific conformational preferences. 
To this end we have recently reported the synthesis of a few 
(poly)hydroxy-substituted 2,3-methanopipecolic acids (which 
we called CPAs, cyclopropane pipecolic acids, Figure 1b),13,14 as 
well as the corresponding 4- and 5-amino-substituted 
derivatives (Figure 2).14 We have employed the latter as γ- and 
δ-amino acids to build RGD-containing cyclopeptides 
mimicking the loop of the natural αVβ3 and α5β1 integrin 
ligands involved in the recognition,15 and which displayed 
nanomolar activity towards both receptors.14,16 However, to 
fully exploit the biomimetic potential of these constrained 
amino acids, their effects on the conformation of both linear 
and cyclic amino acid sequences in which they are embodied 
as α-amino acids had to be evaluated (Figure 2). For instance, 
it is known that the substitution of a pipecolic residue for a 
proline leads to a significant increase in the population of the 
cis conformer,17 and that the cis/trans isomerism around the 
proline amide bond is often associated with important 
biological processes.18 Therefore, the evaluation of how the 
cis/trans isomeric ratio is affected when 2,3-methanopipecolic 
acids replace a proline or a pipecolic acid is a key step toward 
the rational design of bioactive peptidomimetics. 
In this paper we report on a new, simple approach for the 
stereodivergent synthesis of substituted CPAs, their 
incorporation in short linear and cyclic peptides, and a full 
conformational analysis of the latter in comparison, when 
appropriate, with amino acid sequences containing pipecolic 
acid and proline. A particular emphasis is given on the cis/trans 
isomerism around the 2,3-metanopipecolic peptide bond and 
the secondary structure of the linear and cyclic peptides in 
organic solvents and water. 
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Figure 2. Inclusion of cyclopropane pipecolic acids (CPA) in linear and cyclic 
peptides 
 
Results and discussion 
Synthesis of CPAs and their incorporation in linear peptides 
Since we wanted to evaluate the conformational effects of 
diastereomeric 2,3-methanopipecolic acids, a synthetic 
approach different from the OH-directed Simmons-Smith 
cyclopropanation was required.14 Starting from known 
protected lactam 2 (Scheme 1),19 α,β-unsaturated ester 5 was 
prepared in good yield via Pd-catalyzed methoxycarbonylation 
of lactam-derived enol phosphate 4. It was consequently 
subjected to Corey-Chaykovsky cyclopropanation in DMSO 
with dimethylsulfoxonium methylide20 which occurred with 
almost no facial selectivity and provided a 1.4:1 mixture of 2,3-
methanopipecolic acid ester derivatives 6 and 7. These could 
be easily separated by chromatography (40% and 35% yield, 
respectively), this approach thus allowing for the simultaneous 
preparation of both diastereomers in sufficient amounts (> 250 
mg each in a single run from 2) for the next peptide synthesis. 
Moreover, since ent-2 can be prepared from the 
corresponding commercially available precursor [R-(–)-γ-
hydroxymethyl-γ-butyrolactone], all possible stereoisomers of 
these hydroxy-substituted 2,3-methanopipecolic acid 
derivatives can be obtained. 
Additionally, N-Cbz-protected (Cbz: benzyloxycarbonyl) 
compound 7 was easily converted into N-Boc-protected (Boc: 
t-butyloxycarbonyl) derivative 9 in two steps (Scheme 2), while 
starting from diastereomer 6 we tackled the protection of the 
amino group as N-9-fluorenylmethyloxycarbonyl (N-Fmoc) 
which is, besides N-Boc, the other protecting group of choice 
for peptide synthesis. 
Concerning the structure of 6 and 7 (Figure 3), in compound 6 
a NOE correlation observed between 4-H and the endo proton 
of the cyclopropane ring is in accordance with an axial 
orientation of 4-H and a trans-relative position between the 
OTIPS (triisopropylsilyloxy) and the cyclopropane ring (thus an 
S absolute configuration for the Cα atom). On the contrary, no 
NOE was observed between 4-H and the endo proton of the 
cyclopropane ring in compound 7, demonstrating the cis 
relative position of the OTIPS and the cyclopropane ring (thus 
an R absolute configuration for the Cα atom). The low vicinal 
coupling value between 4-H and axial 3-H (1.6 Hz) is consistent 
with an axial orientation of the OTIPS group in 7. 
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Scheme 1. Optimised synthesis of N-CO2Bn protected 4-OTIPS-CPAs. Reagents and 
conditions: a) TIPSCl, imidazole, DMF, 35 °C; b) n-BuLi, CbzCl, THF, -78 °C; c) KHMDS, 
(PhO)2P(O)Cl, THF,  -78 °C; d) MeOH, CO, Pd(OAc)2, Ph3P, Et3N, DMF, 60 °C; e) NaH, 
TMSOI, DMSO, 15 °C. 
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The synthesis of tri- and tetrapeptides embodying our CPAs is 
reported in Schemes 3, 4 and 5. Tripeptide 14 was prepared 
via dipeptide 13 starting from 8 as reported (Scheme 3).14 
Hydrolysis of the ester was carried out to remove the 
hydrophobic benzyl group, thus providing 15 which was 
eventually treated with 1.25 M HCl in anhydrous methanol to 
give methyl ester 16 as a water soluble HCl salt. 
The corresponding diastereomeric compounds were prepared 
from 6 (Scheme 4), the CPA with S absolute configuration at 
the Cα  atom. The coupling of 17 to N-Boc-protected alanine, 
carried out in THF in the presence of DEPBT [3-
(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one] as the 
coupling reagent,21 was complete in 3 days and provided Boc-
Ala-CPA 18 in excellent yield (81%).22  After ester hydrolysis, 
coupling of 19 with H-Gly-OBn was carried out as above and 
was complete in 4 days, furnishing tripeptide Boc-Ala-CPA-Gly-
OBn 20 in 85% yield. The analysis of the 1H NMR spectrum of 
20 in CDCl3 revealed a remarkably high amount of the cis 
isomer (see later) around the amide bond N-terminal to the 
CPA and a downfield chemical shift for the Gly NH proton (δ = 
8.27 ppm) in this isomer, suggesting its possible participation 
to an intramolecular hydrogen bond. This particular 
observation prompted us to remove the N-protection from Ala 
(Scheme 5) and couple 22 with another amino acid (Cbz-Gly-
OH) in order to have a tetrapeptide (23, 67% yield) in which 
the CPA was at the i + 2 position. Removal of the TIPS from 
both 20 (Scheme 4) and 23 (Scheme 5) provided the 
corresponding alcohols 21 (64%) and 24 (65%). Hydrogenation 
of 24 over 10% Pd/C in MeOH and TFA treatment provided 
water soluble peptide 25 as TFA salt in quantitative yield. 
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Scheme 2. Reagents and conditions: a) H2 (1 atm), 10% Pd/C, EtOAc, 25 °C, 18 h; b) 
Boc2O, Et3N, MeOH, reflux, 2h. c) 1 N NaOH, MeOH, 50 °C, 24 h; d) H2 (1 atm), 10% 
Pd/C, EtOAc, 25 °C, 18 h; e) FmocOSu, Na2CO3 aq., THF, 24 h. 
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Figure 3. Stereochemical assignment for compounds 6 and 7 
Conformational analysis of linear peptides incorporating CPAs 
The identification of the cis and trans isomers in compounds 
13-16 and 18-25 (Table 1) is possible by combined NOESY 
studies and analyses of the chemical shifts of the protons at C3 
of the CPA moiety, in CDCl3 or in D2O as appropriate. Because 
of the magnetic anisotropy of the Ala carbonyl group, in all 
examined compounds the 1H NMR signals of the axial and 
equatorial protons at C3 in the cis isomer are always more 
separated than in the trans isomer. In particular, in the cis 
isomers the axial 3-H is more upfield shifted (2.54-3.00 ppm) 
than in the trans isomers (2.93-3.43 ppm) and the equatorial 
3-H is more downfield shifted (3.91-4.56 ppm vs 3.67-3.91 
ppm) (Table S1, Electronic Supplementary Information). This 
assignment is confirmed in the trans isomers by the NOE cross-
peak between the Ala Hα and the CPA 3-Heq, whereas in the cis 
isomers a NOE cross-peak between the Ala methyl group and 
the endo proton of the cyclopropane ring (C7) is diagnostic.  
It has been observed that peptides in which a pipecolic acid 
with S absolute configuration replaces a proline show an 
increase in the population of the cis isomer around the 
pipecolic amide bond. For example the trans/cis ratio in 
compound 28 (Figure 4 and Table 1) is 3:1, whereas the ratio is 
about 12:1 when Pro is in the same position (i+2) (26, Figure 
4).17 This increase has been attributed to the augmented steric 
interaction between the ε position of the pipecolic acid ring 
and the Cα substituent of the preceding residue.17,23  
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Scheme 3. Reagents and conditions: a) H2 (1 atm), 10% Pd/C, EtOH, 25 °C, 23 h; b) 1.25 
HCl in MeOH, 25 °C, 3 h 
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Scheme 4. Reagents and conditions: a) H2 (1 atm), 10% Pd/C, EtOAc, 25 °C, 18 h; b) Boc-
Ala-OH, DEPBT, DIPEA, THF, 35 °C, 3 d; c) NaOH, MeOH, 40 °C, 24 h; d) H-Gly-OBn 
hydrochloride, DEPBT, DIPEA, THF, 35 °C, 4 d; e) TBAF, THF, 25 °C, 2 h. 
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The tendency for a larger cis isomer population is even more 
marked when our 2,3-methanopipecolic acids are at a central 
(i+1 or i+2) or terminal position, with a ratio between the two 
conformers which is affected by the Cα absolute configuration 
of the embodied CPA. When CPA 8, with 1R absolute 
configuration, is the terminal amino acid of a dipeptide 
sequence with N-Boc L-alanine (entry 4, compound 13), the cis 
isomer is the most populated (about 69% of the cis/trans 
mixture) in CDCl3.
24 The relative amount of the cis isomer 
decreases to 45% when the same CPA is the central amino acid 
of tripeptide Boc-Ala-CPA-Gly-OBn 14. The cis relative amount 
only slightly changed in D2O (43%) when the N-Boc protection 
was removed to give tripeptide 16 (entry 7). The formation of 
a weak H-bond between the Gly NH and the Ala carbonyl 
group to form a γ-turn could be invoked to explain the increase 
of the relative amount of the trans isomer of 14 in the organic 
solvent.14 However, for both the trans and cis isomers of 
corresponding tripeptide 16 there is no experimental evidence 
of any turn- or H-bond-stabilized structure in water. In fact, 
variable temperature experiments in D2O/H2O 1:9 (from 20 to 
55 °C) showed that no H-bonded structures exist, as the 
chemical shift temperature coefficients for Gly NH, measured 
at 500 MHz, are -8.57 and -8.0 ppb/K in the cis and trans form, 
respectively, which are in the range of amides not involved in 
H-bond (Figure S1a, ESI). 
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O
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Scheme 5. Reagents and conditions: a) Sn(OTf)2, DIPEA, DCM, 25 °C, 2 h; b) Cbz-Gly-OH, 
DEPBT, DIPEA, THF, 35 °C, 4 d; c) TBAF, THF, 25 °C, 2 h; d) H2, 10% Pd/C, MeOH, 25 °C, 3 
h, then TFA. 
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Figure 4. Simple amino acid sequences embodying proline and pipecolic acid 
Interestingly, by increasing the temperature, we did not 
observe any sign of coalescence nor signal broadening for both 
the Gly NH and the protons of the CPA (e.g. 3-Hax), with the 
chemical shift of the latter remaining practically unchanged 
during the experiments (Figure S1a, ESI). Moreover, there was 
no change in the cis/trans ratio when increasing the 
temperature from 20 to 55 °C. These results strongly indicated 
a high rotational barrier between the cis and trans isomers 
around the CPA amide bond in 16, but its evaluation in water 
was not possible.25 A coalescence temperature of 80 °C at 400 
MHz, corresponding to a rotational barrier ∆Gǂ = 17.8 
kcal/mol, has been instead measured in water for pipecolic 
acid derivative 27 (Figure 4).23 The rotational barrier of 16 was 
thus computationally evaluated by umbrella sampling followed 
by a potential of mean force (PMF) analysis,26 in comparison 
with the same peptide embodying a pipecolic acid (m 16) 
(Figure 5, see also ESI for additional details). 
For the CPA derivative 16, a barrier of 19.2 kcal/mol was 
obtained, whereas a barrier of about 1 kcal/mol lower was 
obtained for the corresponding peptide with pipecolic acid. 
Thus, the presence of the cyclopropane ring in CPA not only 
causes an increase of the cis isomer population (Table 1), but it 
also determines an increase of the rotational barrier, bringing 
it closer to that measured for the prolyl cis/trans 
isomerization.27 
When CPA 11, having 1S absolute configuration at the Cα, is 
the terminal amino acid of the Boc-Ala-CPA dipeptide, the 
relative amount of the cis isomer in CDCl3 also increases 
compared to the corresponding peptides containing pipecolic 
acid, as found for both methyl ester 18 (entry 8) and free acid 
19 (entry 9) (60 and 50%,  
Table 1. Relative amount of cis isomer in the studied compounds 
N
O
NHR''
N COR'
O
NHR''
COR'
trans cis
RO RO
α
 
Entry Compd Cα 
config. 
R R' R'' Solvent % 
cis 
1 26 - - - - D2O 8 
2 27 - - - - D2O 28 
3 28  - - - - D2O 25 
4 13 R TIPS OMe Boc CDCl3 69 
5 14 R OH Gly-OBn Boc CDCl3 45 
6 15 R OH Gly-OH Boc CD3OD 25 
7 16 R OH Gly-OMe H D2O 43 
8 18 S TIPS OMe Boc CDCl3 60 
9 19 S TIPS OH Boc CDCl3 50 
10 20 S TIPS Gly-OBn Boc CDCl3 92 
11 21 S OH Gly-OBn Boc CDCl3 80 
12 22 S TIPS Gly-OBn H CDCl3 88 
13 23 S TIPS Gly-OBn Cbz-Gly CDCl3 86 
14 24 S OH Gly-OBn Cbz-Gly CDCl3 79 
15 25 S OH Gly-OH H-Gly D2O 42 
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respectively). Diminished steric repulsions between the Ala 
side chain and the Cα position of the CPA, as a consequence of 
the replacement of the pipecolic acid Csp3-H bond with a 
cyclopropane C-C bond pointing away from the preceding 
amino acid side chain, could explain the increase of the cis 
isomer molar fraction in CPA-embodying peptidomimetics.28   
When 11 is central in a sequence, as in tripeptide 20 (entry 
10), the cis/trans ratio is even more markedly shifted toward 
the cis isomer which becomes predominant (92%) in CDCl3. 
This also occurs with the corresponding 4-OH substituted 
tripeptide 21 (entry 11) although the relative amount of the cis 
isomer is lower (80%).  
Detailed solution 1H NMR studies on both peptides 20 and 21 
in CDCl3 revealed the presence of a type VI β-turn-like 
structure involving the cis isomers. The type VI β-turn is a 
relatively uncommon protein secondary structure which 
involves a cis peptide bond N-terminal to a L-proline residue 
situated at the i + 2 position.29 The H-bond between the NH of 
the fourth amino acid (i+3) and the carbonyl group of the first 
amino acid specifically characterizes a type VIa β-turn. In our 
peptides, if the Boc carbonyl group is thought as the carbonyl 
group of the i amino acid in the sequence, then the CPA 
occupies the i + 2 position and the stage is set for the 
organization of this secondary structure. In both tripeptides, 
the cis conformation of the major isomer was demonstrated 
by the NOE between the methyl group of the alanine and the 
endo 7-H proton (Figure 6). Moreover, in the 1H NMR spectrum 
the signals of 3-Hax and 3-Heq in the major isomer are more 
separated (Table S1) than in the trans isomer, confirming this 
assignment. A NOE between Gly NH and Ala Cα-H suggests 
that Gly NH is correctly orientated to possibly form an H-bond 
with the Boc carbonyl group, which would nucleate the 10- 
membered type VIa β-turn structure. Consistently, in the cis 
isomer the 3JNH,CHα coupling constant of the alanine residue is 
4.8 Hz (in the trans isomer is much larger, 8.0 Hz), 
corresponding to a dihedral angle of about 125° between the 
two protons, thus indicating that a substantial fraction of the 
cis isomer adopts a folded secondary structure.  
 
 
Figure 5. Energy barrier calculated for the cis-trans isomerization of the amide bond 
connecting Ala and CPA (peptide 16) and that of a model peptide where CPA is 
replaced by the corresponding pipecolic acid (peptide m 16). 
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Figure 6. NOE correlations in compounds 20-23 and 25.  
 
The occurrence of the H-bond between Gly NH and the Boc 
C=O group is further suggested by the markedly deshielded 
(8.28 and 8.37 ppm) signals of the Gly NH proton in the cis 
isomer of both compounds (in the trans isomers it resonates at 
6.47 and 6.57 ppm). Very interestingly, the cis/trans ratio 
changed just a little upon removal of the Boc group to give 22, 
which clearly demonstrates that it is the presence of the CPA 
scaffold that mainly causes the predominance of the cis isomer 
in the organic solvent. In the major isomer of 22 (in a 7:1 ratio 
with the minor isomer) the methyl group of Ala has a NOE 
cross-peak with the endo 7-H proton (Figure 6) which is 
consistent with a cis geometry. Gly NH now resonates more 
upfield shifted (at 7.03 ppm), being not engaged in H-bonding, 
but still shows a NOE cross-peaks with Ala Hα. Moreover, Gly 
NH shows a NOE also with 3-Hax which suggests a downward 
rotation of the CPA carbonyl group toward a favoured bisected 
conformation of the cyclopropane ring.30 
These observations, together with the slightly decrease in the 
cis/trans ratio compared to 20, suggest that the H-bond should 
actually contribute to a further stabilization of the cis isomer in 
the latter compound. To ascertain that the same secondary 
structure is present in a true tetrapeptide with CPA 11 at the i 
+ 2 position, we studied compounds 23 and 24 in CDCl3, and 25 
in water. The 1H NMR analysis of tetrapeptides 23 and 24, 
which were obtained as 6:1 and 3.8:1 mixtures, respectively, of 
cis and trans isomers (Table 1), confirmed the presence of the 
type VIa β-turn secondary structure in CDCl3 for the major (cis) 
isomer (Figure 6). First, the 3JNH,CHα coupling constant of the 
alanine residue in the cis isomer (5.2 Hz for both compounds) 
suggests that the cis isomer mostly adopts a folded secondary 
structure. Then, the pattern of NOE correlations was the same 
than in compounds 20 and 21 and stronger evidences of an H-
bond between NH (i+3) and C=O (i) were found, at least for 23. 
The larger ∆δ between 3-Hax and 3-Heq (1.6-1.85 ppm) (Table 
S1), the NOE between the alanine methyl group and the endo 
7-H proton of the cyclopropane ring and the NOE cross-peak 
between Ala Hα and the amide proton of Gly (i+3) (Figure 6) in 
the major isomer are in accordance with the cis conformation 
of the CPA amide bond. The downfield chemical shift of Gly 
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(i+3) NH (δ = 7.91 ppm in 23) suggests its participation in the 
intramolecular H-bonding with the carbonyl group of Gly (i). A 
solvent titration study carried out by adding increasing 
amounts of DMSO-d6 (from 1.6 to 23% v/v) to a 9 mM solution 
of 23 in CDCl3 was conclusive about the formation of such H-
bond. In fact, we observed a very small variation of Gly (i+3) 
NH chemical shift (Figure 7) in the major isomer, whereas the 
other amide protons were markedly downfield shifted upon 
increasing the relative amount of DMSO-d6. The H-bond 
between Gly (i+3) NH and Gly (i) C=O becomes weaker when 
TIPS protection is removed from 23, as in compound 24 Gly 
(i+3) NH resonate more upfield shifted (7.63 ppm). 
Interestingly, removal of the large TIPS protecting group from 
20 and 23 caused an increase of the trans isomer molar 
fraction in both alcohols 21 and 24.  The trans isomers of 20 
and 23 should reasonably be less favoured because of the 
presence of the large group at C4 which could cause 
unfavourable steric interactions with Ala side chain and CHα. 
In compound 24, the Ala (i+1) NH resonates more downfield at 
7.17 ppm (at 6.41 ppm in 23) suggesting some H-bonding 
involving this proton (e.g. with the Cbz C=O group). A 
conformational search carried out on 24 and including NOE 
derived restraints (Table S2, ESI) resulted in nine 
conformations in a 2 kcal/mol interval, with the global 
minimum conformer showing a H-bond between the Cbz C=O 
group and Ala NH, but not the one between Gly (i) C=O and Gly 
(i+3) NH. The latter is instead present in an energetically higher 
conformation (ΔE = 1.6 kcal/mol) to give the type VIa β-turn 
structure that was anticipated by the 1H NMR studies (Figure 
S3, ESI).  
The 1H NMR analysis of tetrapeptide 25 in water (10 mM 
solution in D2O/H2O, 1 : 9) revealed a greater separation of the 
3-Hax and 3-Heq chemical shifts in the minor isomer (∆δ = 1.37 
ppm vs. 0.76 in the major isomer, Table S1) and a NOE 
between Ala Hα and 3-Heq in the major isomer. This allowed us 
to conclude that in this solvent there is a marked decrease of 
the relative amount of the cis isomer (42%, Table 1), although 
its molar fraction is still greater than that of the cis isomer in 
the corresponding tetrapeptide 28 (25% in water) embodying 
a pipecolic acid in the same position.  
 
Figure 7. DMSO-d6 titration study of compound 23 in CDCl3. 
The NOE pattern in the cis isomer of 25 (Figure 6) is the same 
observed in organic solvent for compound 23. In fact, cross-
peaks between the Ala methyl group and the endo 7-H proton, 
between Gly (i+3) NH and Ala Hα, and most important, 
between Gly (i+3) NH and 3-Hax, suggest that a substantial 
fraction of the conformers possessing the cis CPA amide bond 
adopts a geometry with the cyclopropane ring bisected by the 
CPA carbonyl group [with the consequent lack of H-bonding 
between Gly (i+3) NH and Gly (i) C=O]. The same NOE between  
Gly (i+3) NH and 3-Hax is present in the trans isomer (Figure 6), 
for which we also observe a cross-peak between Gly (i+3) NH 
and the Ala methyl group. Variable temperature experiments 
(from 20 to 65 °C) carried out on 25 in water at 500 MHz 
resulted in large ∆δ/∆T for all amide protons (from -6.57 to -
7.71 ppb/K, Figure S1b) in both rotamers as none of them is 
engaged in H bonding. Interestingly, the cis/trans ratio in 
water seems independent on the absolute configuration of the 
CPA embodied in the peptide, as the same ratio was observed 
in peptide 16 embodying  a (1R)-CPA. Similarly to compound 
16, in 25 no sign of coalescence was observed while increasing 
the temperature for both the amide and CPA protons of 25, 
the chemical shift of the latter remaining unchanged during 
the experiments. Moreover, there was no change in the 
cis/trans ratio when increasing the temperature from 20 to 65 
°C. Again, these results were strongly indicative of a high 
rotational barrier in water between the cis and trans isomers 
around the CPA amide bond.27  
 
Figure 8. Representative conformations of the four principal clusters obtained from the 
analysis of the 300 K trajectory obtained by REMD simulations on peptide 25. 
Populations are referred to the analysis of the 300 – 400 ns. Selected distances are 
reported in Å, angles in degrees. 
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Replica Exchange Molecular Dynamic (REMD) simulations were 
performed on peptide 25 by adapting a protocol previously 
used to simulate the folding of short peptides bearing non-
natural amino acids in their sequence.31 The REMD trajectory 
obtained at 300 K was then analyzed by clustering, providing 
the four main conformations depicted in Figure 8. 
Two conformations present a cis geometry around the CPA 
amide bond (clusters #1 and #4, having populations of 50.7 
and 5.9%) while the other two show a trans geometry (#2 and 
#3, having populations of 23.2 and 19.8%). The two 
components of each cis or trans pair differ by the orientation 
of the amino acidic carbonyl of the CPA residue, that in one 
case points “upward” (conformations #2 and #4). Compared to 
the experimental values, the overall cis population (56.6%) 
appears overestimated, but the principal geometry fits well 
with NOE findings. In fact, in the most populated cis isomer 
(conformation #1, Figure 8), the Gly (i+3) NH has a distance to 
3-Hax of 2.23 Å, compatible with the NOE observed. A similar 
distance (2.32 Å) was measured for the minor trans conformer 
(#3, Figure 8), in accordance with the experimental NOE. The 
trans conformation #2 presents a distance between the Gly 
(i+3) NH and the Ala C=O group of 2.45 Å, which might suggest 
the presence of an H-bond, although not observed 
experimentally. However, a N-H···O angle of 113.2° indicates 
that such an interaction, if it exists,32 is very weak and cannot 
by itself stabilize the γ-turn conformation, in line with the NMR 
results. 
 
Synthesis of a cyclopeptide embodying a CPA 
To evaluate the cis/trans isomerism around the CPA amide 
bond in a cyclic peptide and the conformational changes 
undergone by the latter, because of our interest in integrin 
receptor ligands14,16 we decided to include CPA 8 into a 
cyclopeptide analogous to Cilengitide.33 This is a known αVβ3 
receptor antagonist which has in its sequence Arg, Gly, Asp 
and the unnatural D-Phe and N(Me) Val amino acids.34 CPA 8 
was pictured to substitute the latter amino acid, as the 
remaining sequence D-Phe-Asp-Gly-Arg is responsible for the 
recognition.33b The synthesis in solution of cyclopeptide 35 is 
reported in Scheme 6 and started with the coupling of CPA 8 
to Boc-D-Phe-OH in the presence of DEPBT as the coupling 
reagent. The coupling proceeded smoothly, although it 
required the usual long time (4 days) to be complete, providing 
29 in 75% yield after chromatography as a mixture of cis (45%) 
and trans isomer (55%) around the CPA amide bond. After 
hydrolysis of the methyl ester group, the coupling with 
dipeptide H-Arg(Mtr)-Gly-OBn was similarly uneventful, 
providing tetrapeptide 31 (molecular ion at m/z 1076 [M+ + 1]) 
in 77% yield as a 1.4:1 mixture of rotamers. Finally, after 
quantitative deprotection of D-Phe amino group to give 32, 
further coupling with Cbz-Asp(t-Bu)-OH gave fully protected 
pentapeptide 33 (molecular ion at m/z 1281 [M+ + 1]) in 75% 
yield. Hydrogenation of 33 over 10% Pd/C then provided 34 
with the two unprotected amino and carboxylic group. The 
cyclization of this intermediate was carried out in a dilute (3.5 
mM) solution in anhydrous THF by using DEPBT as the coupling  
a
N
TIPSO
CO2Me
O
N
TIPSO
CO2H
O
b c
N
TIPSO
O
HN
N
H
NH
NHMtr
O NH
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Scheme 6. Reagents and conditions: a) DEPBT, DIPEA, Boc-D-Phe-OH, THF, 35 °C, 4 d; b) 
1 N NaOH, MeOH, 25 °C, 3 d; c) DEPBT, DIPEA, H-Arg(Mtr)-Gly-OBn, THF, 35 °C, 4 d; d) 
Sn(OTf)2, CH2Cl2, 25 °C, 28 h; e) DEPBT, DIPEA, Z-Asp(OtBu)-OH, THF, 35 °C, 4 d; f) H2, 
10% Pd/C, EtOH, 25 °C, 18 h; g) DEPBT, DIPEA, THF, 35 °C, 4 d; h) TBAF, THF, 25 °C, 4 h; 
i) TFA/TIS/H2O 95:2.5:2.5, 25 °C, 18 h. 
reagent, which furnished, after exhaustive deprotection, 
macrocycle 35 (molecular ion at m/z 615 [M+ + 1]) in 12% yield 
over three steps and after HPLC purification (94% purity). 
 
Conformational analysis of CPA-embodying cyclopeptide 35 
The structure and connectivity of peptidomimetic 35 was 
unambiguously assigned by means of mono- and 
bidimensional 1H NMR spectroscopy in aqueous solution (all 1H 
NMR data are reported in Table S3 in ESI) which revealed the 
presence of a major species (86%) we could ascribe to the cis 
isomer around the CPA amide bond. The resonance separation 
of the 3-H protons (∆δ = 0.58 ppm in D2O and 0.77 ppm in 
CD3OD) is in fact very similar to that observed in the cis isomer 
of compound 29 and, moreover, we did not find any NOE 
cross-peak between the CHα of D-Phe and those at C3 of the 
CPA. Instead, a NOE cross-peak between the CHα of D-Phe and 
the endo proton (7-H) of the cyclopropane ring confirms the cis 
geometry (Figure 9a). A weak NOE is also found between the 
ortho protons of the D-Phe phenyl ring and the endo 7-H. Most 
data suggest the existence of a preferred conformation for 
ligand 35, even though the temperature coefficient values 
between -4.28 and -7.1 ppb/K (Figure S6, ESI) indicate that 
none of the N-H protons is tightly locked in an intramolecular 
H-bonded state. 
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Figure 9. (a) NOE correlations in cyclic peptide 35. (b) Representative geometry of the 
most populated cluster obtained by REMD simulation on cyclopeptide 35, followed by 
cluster analysis of the last 50 ns of the 300K trajectory. Distances corresponding to 
experimental NOEs are shown. 
 
The evaluation of the NOE contacts showed the presence of 
two medium-strong sequential CHα(i)/NH(i+1) cross-peaks 
along the Arg-Gly-Asp sequence, whereas such contact could 
not be found between the CHα of Asp and the N-H of D-Phe. A 
strong NOE contact, very useful for the determination of the 
putative preferred conformation in solution, was found 
between the N-H of Arg and the exo proton (7-H) of the 
cyclopropane ring, suggesting an orientation of the N-H bond 
toward the small ring (Figure 9a). Given the “upward” 
preferred orientation of Arg N-H toward the 7-H, the existence 
of a NOE cross-peak between the N-H of Gly and the CHα of 
Arg, indicates that Gly N-H points “downward”, with the Arg 
carbonyl group instead pointing “upward” to form a γ-turn 
with Asp N-H. This is corroborated by the relatively low 
chemical shift value of Asp N-H (7.97 ppm), the relatively high 
3
JNH-αH coupling constant (9 Hz), as well as the lowest 
temperature coefficient (-4.28 ppb/K) for this amide proton. 
However, Gly N-H does not seem engaged in H-bonds (e.g. in a 
possible γ-turn with the carbonyl group of CPA) as the high 
chemical shift value (8.77 ppm) and temperature dependence 
(-7.1 ppb/K) suggest. As a further indication of the existence of 
a preferred conformation in aqueous solution, the two 
diastereotopic CHα of Gly resonate as highly separated dds 
(4.19 and 3.37 ppm) and, moreover, only one of them (i.e. that 
at 4.19 ppm) shows a cross-peak with the N-H of Asp. 
REMD simulations on compound 35, followed by cluster 
analysis of the 300K trajectory, resulted in three main 
conformations (Figure S4, ESI), approximately in a 65:20:14 
ratio and all with cis configuration at the CPA amide bond (four 
other conformations have collectively totaled the 1% of the 
overall population). The spatial orientation of the NH and C=O 
groups in the most populated conformation (Figure 9b), as 
well as the measured distances, perfectly matches with the 
NOE correlations found in 35. The Arg N-H actually points 
towards the exo proton (7-H) of the cyclopropane ring allowing 
an energetically favored bisected conformation of the 
cyclopropane ring with the CPA carbonyl group.30 Moreover, 
the analysis of the most representative conformer of 35 
indicates the formation of the γ-turn between the Arg carbonyl 
group and Asp NH (H···O distance = 2.10 Å, N-H···O angle = 
139.3°) as predicted by the NMR analysis. 
Interestingly, a comparison of the reported preferred 
conformation of Cilengitide in water33b with that of ligand 35 
resulted in the same relative orientation of the side chains of 
D-Phe, Asp and Arg, as well as of the N-H and CO groups of the 
latter. The γ-turn between the Arg carbonyl group and Asp NH 
residue in Cilengitide was also present in 35. The 
superimposition of the most representative geometry of 35 
with that of Cilengitide co-crystallized with the extracellular 
segment of integrin αVβ3,
35a resulted in a RMSD = 1.07 Å 
evaluated on the backbone atoms, with a good match of the 
side chains (Figure S5, ESI). The calculated distance between 
the β carbon atoms of Asp and Arg residues (7.8 Å), an 
important parameter for αVβ3 affinity, was slightly shorter 
than that in Cilengitide (8.9 Å).35 Although out of the scope of 
this work, compound 35 was tested on M21 human melanoma 
cells expressing high levels of αVβ3 heterodimer and actually 
showed capacity to inhibit binding of the cells to vitronectin 
(IC50 = 150 ± 50 nM), but less than Cilengitide (3.8 ± 1.7 nM) 
(Figure S8, ESI).36 
Conclusions 
In conclusion, 2,3-methanopipecolic acids (herein referred 
Cyclopropane Pipecolic Acids, CPAs) are conformationally 
constrained α-amino acids which can be incorporated into 
amino acid sequences to build linear and cyclic 
peptidomimetics. The coupling of the CPA N-terminus to other 
amino acids is much slower if compared to proline (3-4 days vs. 
4-6 h) under the best conditions, but nevertheless it provides 
the target peptide in excellent yield. A thorough 
conformational analysis of the latter allowed us to conclude 
that when embodied in short (three to four) amino acid 
sequences, the presence of a cyclopropane pipecolic acid 
determines a noticeably increase of the cis isomer around the 
CPA amide bond, whose relative amount (42-92%) in both 
water and organic solvent is always and markedly higher than 
in the corresponding peptides containing a simple pipecolic 
acid or a proline. In organic solvent (CDCl3), the cis/trans 
isomer ratio depends on the absolute configuration of the CPA 
Cα atom, with the cis isomer becoming predominant (79-92%) 
in tri- and tetrapeptides embodying a CPA with 1S absolute 
configuration. In this solvent, when (1S)-CPA is in the i+2 
position, it forces the peptide to fold into a type VIa β-turn 
secondary structure. Instead, in water, the relative amount of 
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the cis isomer decreases to 42-43% irrespective of the Cα 
absolute configuration of the used 2,3-methanopipecolic acid, 
with the loss of the secondary structure found in CDCl3. Finally, 
in these short peptides, the calculated rotational barrier 
around the CPA amide bond (19.2 kcal/mol) in water is larger 
than that measured or calculated for the corresponding 
peptides embodying a simple pipecolic acid. CPAs are suitable 
to be incorporated as α-amino acids in cyclic peptides, too. As 
an example, the inclusion of a CPA for a N(Me)Val in the amino 
acid sequence of Cilengitide generated a cyclic 
peptidomimetic, in which the cis isomer was still predominant, 
with low RMSD (1.07 Å) on backbone atoms and similarly 
oriented side chains.  
Because of their features, in particular the preferential cis 
geometry and the high rotational barrier around the CPA 
amide bond, cyclopropane pipecolic acids are suitable to be 
incorporated in peptidomimetics as constrained α-amino acids 
as tools for probing protein-ligand interactions and generating 
novel bioactive compounds. 
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(all four stereoisomers)
 
When 2,3-methanopipecolic acids replace a proline in peptides, a marked preference (42-92%) for 
the cis geometry around the pipecolic amide bond is observed in both water and organic solvent.  
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